Johnson & Johnson

NYSE:JNJUnited States

Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. Products in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, interventional solutions, cardiovascular intervention, and vision fields. The MedTech segment also offers a commercially available intravascular lithotripsy (IVL) platform for coronary artery disease (CAD) and peripheral artery disease (PAD).

Contact Information

Headquarters

One Johnson & Johnson PlazaNEW BRUNSWICK, NJ, United States 08933

Phone

732-524-2455

Fax

732-214-0332

Executives

Chairman of the Board, Chief Executive Officer

Joaquin Duato

Chief Financial Officer, Executive Vice President

Joseph Wolk

Chief Human Resource Officer, Executive Vice President

Peter Fasolo

Executive Vice President, Chief Technology Officer and Risk Officer

Kathryn Wengel

Executive Vice President, Chief Information Officer

James Swanson